Interpace Biosciences, along with its subsidiaries, entered into an $8 million term loan with BroadOak Fund V. Interpace Biosciences used the proceeds primarily to repay principal and interest on the $7.5 million short-term promissory notes due to the company’s two private equity stockholders.